GBA mutations associated with intestinal permeability maintenance may cause intestinal inflammation and subsequent systemic inflammation which may increase risk of PD. Together with dopaminergic cells death and microglial activation, GBA mutations may lead to neurodegeneration and PD. This evidence concerns the gene GBA1 and Parkinson disease.